Allied Healthcare Product (AHPI) has a profit margin of -20.16%, below the Healthcare sector average of 10.58%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2022
Trailing 12 months ending Jun 2022
The latest profit margin for AHPI is -20.16% as of June 2022. That compares with 4.65% in the prior-year period — down 533.4% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Allied Healthcare Product's historical trend and sector peers before judging valuation or financial health.
Over the past year, AHPI's profit margin moved from 4.65% to -20.16% — a 533.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Allied Healthcare Product's valuation or profitability profile.
Against Healthcare companies, AHPI currently prints -20.16% for profit margin, while the sector average sits near 10.58%. That is roughly 290.5% below the sector mean. Large gaps often invite a closer look at Allied Healthcare Product's growth, margins, and balance sheet.
Profit Margin shows how effectively Allied Healthcare Product converts resources into returns. At -20.16%, AHPI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 4.65% in the prior-year period — down 533.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting AHPI's profit margin (-20.16%), review year-over-year change from 4.65%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.